CID 118110201

Slc391

Structural Information

Molecular Formula
C19H23N7O
SMILES
C1CC1CC2=NN=C(O2)C3=C(N=CC(=C3)C4=CN(N=C4)C5CCNCC5)N
InChI
InChI=1S/C19H23N7O/c20-18-16(19-25-24-17(27-19)7-12-1-2-12)8-13(9-22-18)14-10-23-26(11-14)15-3-5-21-6-4-15/h8-12,15,21H,1-7H2,(H2,20,22)
InChIKey
JYVSYFGHYFXYBE-UHFFFAOYSA-N
Compound name
3-[5-(cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

421
Patents

365.1964 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 366.20368 188.7
[M+Na]+ 388.18562 203.5
[M+NH4]+ 383.23022 194.7
[M+K]+ 404.15956 202.2
[M-H]- 364.18912 201.7
[M+Na-2H]- 386.17107 199.0
[M]+ 365.19585 195.4
[M]- 365.19695 195.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe